Abstract
MT1 and MT2, polypeptides from green mamba venom, known to bind to muscarinic cholinoceptors, behave like muscarinic agonists in an inhibitory avoidance task in rats. We have further characterised their functional effects using different preparations. MT1 and MT2 behaved like relatively selective muscarinic M1 receptor agonists in rabbit vas deferens, but their effects were not reversed by washing or prevented by muscarinic antagonists, although allosteric modulators altered responses to MT1. Radioligand binding experiments indicated that both toxins irreversibly inhibited [3H]N-methylscopolamine binding to cloned muscarinic M1 and M4 receptors, and reduced binding to M5 subtype with lower affinity, while they reversibly inhibited the binding of [3H]prazosin to rat cerebral cortex and vas deferens, with 20 fold lower affinity. High concentrations of MT1 reversibly blocked responses of vas deferens to noradrenaline. MT1 and MT2 appear to irreversibly activate muscarinic M1 receptors at a site distinct from the classical one, and to have affinity for some α-adrenoceptors.
Similar content being viewed by others
REFERENCES
Adem, A., Asblom, A., Johansson, G., Mbugua, P. M., and Karlsson, E. 1988. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochim. Biophys. Acta 968:340-345.
Ducancel, F., Rowan, E. G., Cassar, E., Harvey, A. L., Ménez, A., and Boulain, J.-C. 1991. Amino acid sequence of a muscarinic toxin deduced from the cDNA nucleotide sequence. Toxicon 29:516-520.
Karlsson, E., Risinger, C., Jolkkonen, M., Wernstedt, C., and Adem, A. 1991. Amino acid sequence of a snake venom toxin that binds to the muscarinic acetylcholine receptor. Toxicon 29:521-526.
Jerusalinsky, D., Cerveñansky, C., Peña, C., Raskovsky, S., and Dajas, F. 1992. Two polypeptides from Dendroaspis angusticeps venom inhibit selectively the binding of central muscarinic cholinergic receptor ligands. Neurochem. Int. 20:237-246.
Jolkkonen, M., Adem, A., Hellman, U., Wernstedt, C., and Karlsson, E. 1995. A snake toxin against muscarinic acetylcholine receptors: Amino acid sequence, subtype specificity and effect on guinea-pig ileum. Toxicon 33:399-410.
Kornisiuk, E., Jerusalinsky, D., Cerveñansky, C., and Harvey, A. L. 1995. Binding of muscarinic toxins MTx1 and MTx2 from the venom of the green mamba Dendroaspis angusticeps to cloned human muscarinic cholinoceptors. Toxicon 33:11-18.
Kornisiuk, E., Jerusalinsky, D., Cerveñansky, C., and Harvey, A. L. 1995. Binding of muscarinic toxins MTx1 and MTx2 from the venom of the green mamba Dendroaspis angusticeps to cloned human muscarinic cholinoceptors. Corrigendum. Toxicon 33:1111.
Jerusalinsky, D., Harvey, A. L., and Kornisiuk, E. 1997. Muscarinic toxins and muscarinic acetylcholine receptors. Pages 35-52, in Gutman, Y. and Lazarovici, P. (eds.), Toxins and Signal Transduction, Harwood Academic, Amsterdam.
Jerusalinsky, D., Alfaro, P., Kornisiuk, E., Quillfeldt, J., Alonso, M., Rial Verde, E., Durán, R., and Cerveñansky, C. 2000. Muscarinic toxins: Novel pharmacological tools for the muscarinic cholinergic system. Toxicon 38:747-761.
Jerusalinsky, D., Cerveñansky, C., Walz, R., Bianchin, M., and Izquierdo, I. 1993. A peptide muscarinic toxin from the green mamba venom shows agonist-like action in an inhibitory avoidance learning task. Eur. J. Pharmacol. 240:103-105.
Jerusalinsky, D., Kornisiuk, E., Bernabeu, R., Izquierdo, I., and Cerveñansky, C. 1995. Muscarinic toxins from the venom of Dendroaspis snakes with agonist-like actions. Toxicon 33:389-397.
Jerusalinsky, D., Raskovsky, S., Kornisiuk, E., Bernabeu, R., and Cerveñansky, C. 1994. Muscarinic toxins from the venom of elapid snakes. Pages 89-102, in Tipton, K. and Dajas, F. (eds.), Neurotoxins in Neurobiology: Their Actions and Applications, Ellis Horwood, Chichester.
Caulfield, M. P. 1993. Muscarinic receptors-characterization, coupling and function. Pharmacol. Ther. 58:319-379.
Eltze, M. 1988. Muscarinic M1-and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur. J. Pharmacol. 151:205-221.
Eltze, M., Gmelin, G., Wess, J., Strohmann, C., Tacke, R., Mutschler, E., and Lambrecht, G. 1988. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type. Eur. J. Pharmacol. 158:233-242.
Grimm, U., Fuder, H., Moser, U., Baumert, H. G., Mutschler, E., and Lambrecht, G. 1994. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:1-10.
Nilsson, B. M., Vargas, H. M., and Hacksell, U. 1992. Amide, urea, and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride. J. Med. Chem. 35:2787-2798.
Fiszman, M., Luchelli-Fortis, M., and Stefano, F. 1989. Amphetamine antagonizes the presynaptic inhibitory effect of clonidine through an interaction at the level of the α2-adrenoceptors. Gen. Pharmacol. 20:351-358.
Dorje, F., Rettenmayr, N. M., Mutschler, E., and Lambrecht, G. 1991. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens. Eur. J. Pharmacol. 203:417-420.
Doxey, J. C., Roach, A. G., and Smith, C. F. C. 1983. Studies on RX781094: A selective, potent and specific antagonist of α2-adrenoceptors. Br. J. Pharmacol. 78:489-505.
Dorje, F., Wess, J., Lambrecht, G., Tacke, R., Mutschler, E., and Brann, M. R. 1991. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exper. Ther. 256:727-733.
Belleau, B., Benfey, B. G., and Melchiorre, C. 1982. Presynaptic effect of clonidine antagonized by the tetramine disulphide, benextramine. Br. J. Pharmacol. 75:617-621.
Young, J. M., Hiley, R., and Burgen, A. S. V. 1972. Homologues of benzilylcholine mustard. J. Pharm. Pharmacol. 24: 950-954.
Barlow, R. B., McMillen, L. S., and Veale, M. A. 1991. The use of 4-diphenylacetoxy-N-(2-chloroethyl)-piperidine (4-DAMP mustard) for estimating the apparent affinities of some agonists acting at muscarinic receptors in guinea-pig ileum. Br. J. Pharmacol. 102:657-662.
Stockton, J. M., Birdsall, N. J. M., Burgen, A. S. V., and Hulme, E. C. 1983. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23:551-557.
Potter, L. T., Ferrendelli, C. A., Hanchett, H. E., Hollifield, M. A., and Lorenzi, M. V. 1989. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal m1 muscarine receptors. Mol. Pharmacol. 35:652-660.
Jerusalinsky, D. and Harvey, A. L. 1994. Toxins from mamba venoms: Small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 15:424-430.
Bradley, K. 2000. Muscarinic toxins from the green mamba. Pharmacol. Ther. 85:87-109.
Max, S. I., Liang, J.-S. Valentine, H. H., and Potter, L. T. 1993. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J. Pharmacol. Exper. Ther. 267:480-485.
Max, S. I., Liang, J.-S., and Potter, L. T. 1993. Stable allosteric binding of m1-toxin to m1 muscarinic receptors. Mol. Pharmacol. 44:1171-1175.
Max, S. I., Liang, J.-S., and Potter, L. T. 1993. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J. Neurosci. 13:4293-4300.
Adem, A. and Karlsson, E. 1997. Muscarinic receptor subtype selective toxins. Life Sci. 60:1069-1076.
Jolkkonen, M., van Giersbergen, P. L. M., Hellman, U., Wernstedt, C., and Karlsson, E. 1994. A toxin from the green mamba Dendroaspis angusticeps: Amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett. 352:91-94.
Max, S. I., Liang, J.-S., Purkenson, S. L., and Potter, L. T. 1993. M4-toxin, a selective, reversible, allosteric antagonist of m4 muscarinic receptors. Soc. Neurosci. Abstr. 19:462.
Adem, A., Jolkkonen, M., Bogdanovic, N., Islam, A., Winblad, B., and Karlsson, E. 1995. Distribution of m4 muscarinic cholinergic receptors in the rat brain detected by a selective mamba toxin (MT-3). Life Sci. 56:1013.
Olianas, M. C., Adem, A., Karlsson, E., and Onali, P. 1996. Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: Potent block by the selective m4 ligand muscarinic toxin (MT3). Brit. J. Pharmacol. 118:283-288.
Karlsson, E., Jolkkonen, M., Satyapan, N., Adem, A., Kumlin, E., Hellman, U., and Wernstedt, C. 1994. Protein toxins that bind to muscarinic acetylcholine receptors. Ann. N. Y. Acad. Sci. 710:153-161.
Sheardown, M. J., Shannon, H. E., Swedberg, M. D. B., Suzdak, P. D., Bymaster, F. P., Olesen, P. H., Mitch, C. H., Ward, J. S., and Sauerberg, P. 1997. M1 receptor agonist activity is not a requirement for muscarinic antinociception. J. Pharmacol. Exp. Ther. 281:868-875.
Alexander, S. P. H. and Peters, J. A. (eds.), 2000. TiPS Receptor and Ion Channel Nomenclature Supplement (Vol. 11), Elsevier.
Budriesi, R., Cacciaguerra, S., Di Toro, R., Bolognesi, M. L., Chiarini, A., Minarini, A., Rosini, M., Spampinato, S., Tumiatti, V., and Melchiorre, C. 2001. Analysis of the muscarinic receptor subtype mediating inhibition of the neuro genic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines. Br. J. Pharmacol. 132:1009-1016.
Bradley, K. N. 1999. The in vitro effects of muscarinic toxins MT2, MT3, MT4 and MT7 isolated from the venom of Dendroaspis angusticeps. Ph.D. Thesis, University of Strathclyde, Glasgow.
Kornisiuk, E., Sánchez, G., Cerveñansky, C., Durán, R., and Jerusalinsky, D. 2001. Muscarinic toxins and their actions on muscarinic inhibition of adenylyl cyclase activity. J. Neurochem. 78 (Suppl. 1):BP18-37.
Curtis, C. A. M., Wheatley, M., Bansal, S., Birdsall, J. M., Eveleigh, P., Pedder, E. K., Poyner D., and Hulme, E. C. 1989. Propylbenzilylcholine mustard labels and acidic residue in transmembrane helix 3 of the muscarinic receptor. J. Biol. Chem. 264:489-495.
Christopoulos, A., Pierce, T. L., Sorman, J. L., and El-Fakahany, E. E. 1998. On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor. Mol. Pharmacol. 53:1120-1130.
Olianas, M. C., Maullu, C., Adem, A., Mulugeta, E., Karlsson, E., and Onali, P. 2000. Inhibition of acetylcholine muscarinic M1 receptor function by the M1-selective ligand muscarinic toxin 7 (MT-7). Br. J. Pharmacol. 131:447-452.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harvey, A.L., Kornisiuk, E., Bradley, K.N. et al. Effects of Muscarinic Toxins MT1 and MT2 from Green Mamba on Different Muscarinic Cholinoceptors. Neurochem Res 27, 1543–1554 (2002). https://doi.org/10.1023/A:1021660708187
Issue Date:
DOI: https://doi.org/10.1023/A:1021660708187